Skip to Content
Søk Menu

The SPARTAN study – the treatment of non-metastatic castration-resistant prostate cancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relateret indhold

Daniel Heinrich

Highlights from ESMO 2024: More Intelligent Choice of Treatment in the Future

/ Daniel Heinrich
BlærekreftESMO24NyrekreftProstatakreft Play the Video 4:25
Fred Saad

Darolutamide May Be an Effective Alternative Treatment Option for mHSPC

/ Fred Saad
ESMO24Prostatakreft Play the Video 3:46
Live Fagereng

Necessary to Evaluate and Justify Off-Label Use of Oncology Drugs to Provide Equal Access to Effective Treatment

/ Live Fagereng
ESMO24Kreft Play the Video 2:06
Martin Højgaard

Durable Responses and Stable Disease in Multiple ATM-Altered Advanced Cancers

/ Martin Højgaard
ESMO24Kreft Play the Video 09:40

Get in the Perineum! – Refinement of Prostate Biopsy Technique for Patient Safety and Antibiotic Stewardship

/ Lars Boesen
Prostatakreft
Jerome Leow

PSMA PET Staging Significantly Improves Prognosis in Pelvic Node-Positive Prostate Cancer

/ Boon Yang Jerome Leow
Prostatakreft Play the Video 07:19
Thorgerdur Palsdottir

The Capio Model for Prostate Cancer Diagnostics

/ Thorgerdur Palsdottir
ASCO24Prostatakreft Play the Video 8:20

Physical Activity, Fitness, and Cardiovascular Disease Risk in Adolescent Cancer Survivors

/ Mari Bratteteig / Corina S. Rueegg / May Grydeland / Sigmund A. Anderssen / Ellen Ruud
BarnHjerte- og karsykdomKreftTrening
Christina H. Ruhlmann

Updated MASCC/ESMO Guidelines on Prevention of Cancer Therapy-Induced Nausea and Vomiting

/ Christina H. Ruhlmann
BehandlingKjemoterapiKreft Play the Video 7:41
Back to top